Press Releases
Cosmo and Glenmark Announce UK MHRA Approval of Winlevi for Treatment of Acne
Dublin, Ireland and Mumbai, India | London, U.K: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a global research-led...
Articles
The Future of Drug Discovery
The landscape of drug discovery is evolving rapidly, driven by the need for innovative solutions to tackle complex diseases. Traditional R&D models, characterized by...
News
Why Early Intervention Is Key To Managing Chronic Health Concerns
Proactive health management is essential for maintaining a good quality of life, particularly when it comes to chronic health conditions. Early intervention plays a...
IT & Data Management
McKesson Acquires Controlling Stake in PRISM Vision
McKesson Corporation has announced its agreement to acquire a controlling 80% interest in PRISM Vision Holdings, LLC, investing approximately $850 million to expand its...
Drug Research
Thermo Fisher Launches Adolescent Alopecia Areata Registry
Thermo Fisher Scientific Inc., the global leader in serving science, has announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry. This...
BioPharma
Thermo Fisher Partners with X-ELIO for Renewable Energy
Thermo Fisher Scientific has taken a significant step toward achieving its sustainability goals by signing a 10-year virtual power purchase agreement (VPPA) with renewable...
Clinical Trials
New Data Shows Gazyva’s Superiority in Lupus Nephritis
The New England Journal of Medicine has published detailed findings from Roche’s Phase III REGENCY trial, which demonstrated the superiority of Gazyva®/Gazyvaro® (obinutuzumab) in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
